======= SETD1A ======= == Gene Information == * **Official Symbol**: SETD1A * **Official Name**: SET domain containing 1A, histone lysine methyltransferase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9739|9739]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15047|O15047]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SETD1A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETD1A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611052|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a component of a histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated histone H3 at Lys4. Trimethylation of histone H3 at lysine 4 (H3K4me3) is a chromatin modification known to generally mark the transcription start sites of active genes. The protein contains SET domains, a RNA recognition motif domain and is a member of the class V-like SAM-binding methyltransferase superfamily. [provided by RefSeq, Dec 2016]. * **UniProt Summary**: Histone methyltransferase that specifically methylates 'Lys-4' of histone H3, when part of the SET1 histone methyltransferase (HMT) complex, but not if the neighboring 'Lys- 9' residue is already methylated. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. The non-overlapping localization with SETD1B suggests that SETD1A and SETD1B make non-redundant contributions to the epigenetic control of chromatin structure and gene expression. {ECO:0000269|PubMed:12670868}. |RRM 1| |N-SET| |SET| |Set1C/COMPASS complex| |histone methyltransferase activity (H3-K4 specific)| |histone H3-K4 methylation| |histone methyltransferase complex| |regulation of megakaryocyte differentiation| |histone lysine methylation| |regulation of hematopoietic stem cell differentiation| |beta-catenin binding| |regulation of hematopoietic progenitor cell differentiation| |peptidyl-lysine methylation| |histone methylation| |regulation of stem cell differentiation| |protein methylation| |protein alkylation| |regulation of chromatin organization| |regulation of myeloid cell differentiation| |nuclear chromatin| |macromolecule methylation| |methylation| |peptidyl-lysine modification| |transcription factor binding| |regulation of chromosome organization| |histone modification| |covalent chromatin modification| |nuclear speck| |regulation of hemopoiesis| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |regulation of organelle organization| |RNA binding| |regulation of immune system process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.12| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.75| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.8| |[[:results:exp156|UNC2400 2μM R03 exp156]]|1.88| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|2.51| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|3.59| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.581| |[[:human genes:z:znf148|ZNF148]]|0.477| |[[:human genes:i:iscu|ISCU]]|0.454| |[[:human genes:s:slc6a17|SLC6A17]]|0.449| |[[:human genes:b:bod1l1|BOD1L1]]|0.445| |[[:human genes:z:zfand5|ZFAND5]]|0.439| |[[:human genes:p:paf1|PAF1]]|0.437| |[[:human genes:p:psma6|PSMA6]]|0.436| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.435| |[[:human genes:d:dido1|DIDO1]]|0.434| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.414| |[[:human genes:p:ppie|PPIE]]|0.413| |[[:human genes:r:rnf113a|RNF113A]]|0.413| |[[:human genes:c:cdk12|CDK12]]|0.41| |[[:human genes:n:nsf|NSF]]|0.41| |[[:human genes:d:dnm2|DNM2]]|0.409| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.409| |[[:human genes:a:atp6v1c1|ATP6V1C1]]|0.408| |[[:human genes:p:psmb4|PSMB4]]|0.406| |[[:human genes:a:akap1|AKAP1]]|0.405| |[[:human genes:t:tceb3c|TCEB3C]]|0.405| |[[:human genes:r:rnpc3|RNPC3]]|0.403| |[[:human genes:s:sf3a1|SF3A1]]|0.402| |[[:human genes:l:loxl1|LOXL1]]|0.402| Global Fraction of Cell Lines Where Essential: 338/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|12/28| |blood|11/28| |bone|14/25| |breast|19/33| |central nervous system|28/56| |cervix|3/4| |colorectal|3/17| |esophagus|4/13| |fibroblast|1/1| |gastric|8/15| |kidney|9/21| |liver|16/20| |lung|27/75| |lymphocyte|7/14| |ovary|14/26| |pancreas|9/24| |peripheral nervous system|5/16| |plasma cell|7/15| |prostate|1/1| |skin|12/24| |soft tissue|4/7| |thyroid|1/2| |upper aerodigestive|8/22| |urinary tract|11/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 359 * **Expression level (log2 read counts)**: 6.64 {{:chemogenomics:nalm6 dist.png?nolink |}}